Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 9 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

3(75.0%)

Phase 1

1(25.0%)

4Total

N/A(3)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT07092631Completed

Anastomotic Leakage in Colorectal Cancer Surgery in Syria

Role: collaborator

NCT06219603Completed

Knowledge and Awareness About Inflammatory Articular Diseases

Role: lead

NCT06381206Phase 1Completed

Silodosin in Management of Lower Ureteral Stones

Role: lead

NCT03839849Not ApplicableCompleted

Evaluation of Adjunctive Injectable PRF Therapy Used in Conjunction With Scaling and Root Planning

Role: lead

NCT06328595Completed

Muscular and Joint Symptoms in COVID-19 Patients: Insights From Syria

Role: lead

NCT06228911Not ApplicableCompleted

Increased Blood Glucose Levels After Steroid Injection

Role: lead

NCT06190938Completed

Diabetes Complications and Hearing Loss

Role: lead

NCT03863093Not ApplicableCompleted

Evaluation of Air Polishing With Ultrasonic Debridement in the Treatment of Initial Periodontal Pockets

Role: lead

NCT06134726Completed

Temporomandibular Joint in Patients With Rheumatoid Arthritis

Role: lead

All 9 trials loaded